TGTX

TG Therapeutics
TGTX

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$5.36B
EV
$5.33B
Shares Outstanding
149.56M
Beta
1.92

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$41.20
P/E 2025E
43.72x
P/Revenue 2025E
8.98x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About TG Therapeutics, Inc.

gainify
TGTX

TG Therapeutics, Inc.

TGTX

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. It provides BRIUMVI, an anti-CD20 monoclonal ...

Sector

Healthcare

Industry

Biotechnology

CEO

Weiss, Michael

Employees

352

IPO Date

2010-05-03

Headquarters

3020 Carrington Mill Blvd., Suite 475, Morrisville, North Carolina, 27560, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

COMPANY

Pricing

Dashboard

About Us

Contact Us

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.